ISTH 2022 Congress
Coagulation and Natural Anticoagulants » Coagulation Factors and Inhibitors
Theme Navigation
- ISTH 2022 Congress
- Coagulation and Natural Anticoagulants
- Coagulation Factors and Inhibitors
- Coagulation and Natural Anticoagulants
-
Abstract Number: PB0552
A Probable Therapeutic for a Child with Inherited Protein S Deficiency
-
Abstract Number: VPB0572
A study of the stability of fibrinogen and FXIII levels and microbial integrity of pooled cyroprecipitate stored at 1-6°C and 20-24°C for up to 120 hours
-
Abstract Number: OC 36.4
A Tethered Artificial Protease Reveals the Location of Key Regulatory Motifs in Factor V
-
Abstract Number: PB0548
Abelacimab, a Factor XI/XIa Antibody Inhibits Clotting in Hemodialysis Circuits Ex Vivo
-
Abstract Number: OC 65.2
Andexanet alfa is associated with a significant reduction in in-hospital mortality compared to 4F-PCC in a real-world analysis
-
Abstract Number: PB0547
Antithrombin deficiency is associated with more compact plasma fibrin clot structure and impaired susceptibility to fibrinolysis
-
Abstract Number: VPB0570
Assessment of Impact of Metabolites of Edoxaban and Dabigatran on Fibrin and Thrombin Generation Assays
-
Abstract Number: PB0542
Bio-equivalence of Potency adjusted approved heparin solutions compared to a newly developed heparin solution.
-
Abstract Number: PB0561
Ca2+ and Zn2+ binding to human Protein Z (PZ) induces structural changes that augments its lipid binding
-
Abstract Number: PB0564
Combined Molecular Dynamics and Docking Studies on Direct Oral Anticoagulant Binding to Factor Xa Variants
-
Abstract Number: PB0549
Comparative Studies on Clotting and Antiprotease Profile of Heparins of Ovine, Bovine and Porcine Origin
-
Abstract Number: VPB0567
Comparative Studies on the Interaction of Heparins from Various Origins with Heparin Cofactor II and Antithrombin
-
Abstract Number: OC 67.4
Congenital factor VII deficiency in a large cohort of Portuguese patients — molecular profiling, pathogenicity stratification and genotype-phenotype correlation
-
Abstract Number: PB0532
Deciphering the role of small sulfated molecule PTS on AT3 structure and in vitro clot formation.
-
Abstract Number: PB0550
Differential Neutralization of Unfractionated Heparin and Enoxaparin by Andexanet Alfa
-
Abstract Number: PB0557
Effectiveness and safety of Direct Oral Anticoagulants (DOACs) in extremely obese compared to non-extremely obese patients in an observational prospective single-centre unselected patient registry
-
Abstract Number: PB0545
Efficacy and safety of Haemocer, a local hemostatic agent, in patients with congenital bleeding disorders: A pilot study
-
Abstract Number: PB0538
Enzymatic activity of bound thrombin within fibrin fibers